What is happening with the Edward Lifesciences action?

0
36

[Updated: Sep 20, 2021] Edward Lifesciences actions update

A few months ago we discussed it Edward Life Sciences the stock may continue to show higher levels after increasing 10% in one month following positive developments around Resilia tissue valves. EW stock has since risen 16% to currently stand at $ 121. At the end of July, the company announced its second quarter results well above consensus estimates, due to an increase in the volume of catheter aortic valve replacement procedures. In addition, the company has raised its annual outlook for revenue and profit growth at a faster than expected pace, which bodes well for investors.

But now that EW stock has seen a 6% move in the last month or so, while it is up 36% since the start of the year, will it continue its bullish trajectory, or a fall imminent? Based on historical performance, there is still more chances of a rise in EW stock over the next month. Out of 767 instances in the last ten years where EW stock has risen 6% or more over twenty-one days, 477 of these have resulted in an increase in EW stock during the period of a following month (twenty-one trading days). This historic trend reflects 477 out of 767, which is roughly a 62% chance that EW shares will rise in the coming month. See our analysis on Edward Lifesciences Stocks Increase Chances for more details.

Calculation of “probability of event” and “chance of increase” using data from the last ten years

  • After moving -1.4% or more over a five-day period, the stock rose over the next five days 61% of the time.
  • After moving 3.3% or more over a ten-day period, the stock rose over the next ten days 58% of the time
  • After changing 5.8% or more over a twenty-one day period, the stock rose over the next twenty-one days in 62% of cases.

Predict the average return of the Edwards Lifesciences stock return: AI predicts the average and excess return of EW after a fall or rise

Edwards Life Sciences

GE
Comparison of (recent) stock returns with peers

  • Five-day return: Highest BAX at 1%; Lowest -2.6% MTD
  • Ten Day Yield: Highest BAX at 9.6%; ZBH lowest at -3%
  • Twenty-one day return: highest BAX at 10%; ZBH lowest at -0.4%

[Updated: Jun 25, 2021] Rise in EW shares

The share price of Edward Life Sciences, a company specializing in artificial heart valves and hemodynamic monitoring, has seen a 10% increase in the last twenty-one trading days. This can be attributed to the positive result of a clinical trial on the tricuspid system and Pascal Evoque for patients with mitral or tricuspid valve disease. Additionally, the company has seen strong adoption of its Resilia tissue valves in the recent past, a trend that is expected to continue. Earlier this month, the company announced U.S. FDA approval for its Acumen Hypotension Prediction Index software with the Acumen IQ cuff, which provides access to various hemodynamic parameters. The software uses machine learning to send alerts if a patient has low blood pressure.

While there have been some positive developments for the company lately, now that EW stock has seen a 10% rise in twenty-one trading days, will it continue on its upward trajectory or fall? is it imminent? Based on historical performance, there is a greater likelihood of a rise in EW shares over the next month. Out of 387 instances Over the past ten years, Edwards Lifesciences stock has risen by 10% or more in twenty-one days, 228 of them resulted in an increase in the stock of EW during the next month period (twenty-one trading days). This historic trend reflects 228 out of 387, or about 59% chance of a rise in EW shares in the coming month. See our analysis on Chances of increasing Edwards Lifesciences shares for more details.

Calculation of “probability of event” and “chance of increase” using data from the last ten years

  1. After moving 4.6% or more over a five-day period, the stock rose over the next 5 days in 51% of cases.
  2. After fluctuating 7.9% or more over a ten day period, the stock rose over the next 10 days in 54% of cases
  3. After fluctuating 9.8% or more over a twenty-one day period, the stock rose over the next 21 days in 59% of cases

Predict the average return on Edwards Lifesciences market return: AI predicts average and excess return of EW after fall or rise

Comparison of Edwards Lifesciences’ stock performance (recent) to its peers

  • Five-day return: highest EW at 4.6%; Lowest BAX at -1%
  • Ten-day yield: highest EW at 7.9%; 1.7% lowest BAX
  • 21-day yield: highest EW at 9.8%; ABT lowest at -5.5%

While EW stock may experience higher levels, 2020 has created many price discontinuities which may provide some interesting trading opportunities. For example, you’ll be surprised at how counterintuitive stock valuation is to Merck vs. Regeneron

Invest with Trefis Wallets that beat the market

See everything Trefis Price estimates

.

LEAVE A REPLY

Please enter your comment!
Please enter your name here